Introduction
============

Neurodevelopmental disabilities affect millions of children worldwide ([@B29]); it is mainly because the placenta does not block the transmission of many environmental toxicants from the maternal to the fetal circulation ([@B41]). It is known that nanoparticles (NPs), unlike bulk materials, are able to pass through biological barriers, such as the blood--brain barrier (BBB), blood--testis barrier, and placental barrier ([@B34]; [@B78]; [@B4]; [@B40]). Therefore, NPs can localize in various organs and tissues and generate toxicological effects ([@B33]; [@B42]; [@B44]; [@B2]). Although the safety issues are of high importance, related toxicological studies are far behind the development of nanotechnologies ([@B15]). Alumina nanoparticles (AlNP) have unique physical and chemical characteristics compared to bulk alumina (bulk-Al); they are widely used in industries of pharmacy, water treatment, and manufacturing ([@B33]), raising concern of the biological safety regarding public health.

Studies have shown that AlNP can penetrate biological barriers and accumulate in multiple organs ([@B15]; [@B44]; [@B2]; [@B39]), leading to neurotoxicity ([@B44]; [@B20]; [@B76]; [@B16]; [@B58]; [@B38]), immunotoxicity ([@B9]), genotoxicity ([@B5],[@B6]), as well as toxicity in the lung ([@B5]; [@B36]), liver ([@B60]; [@B38]), kidney ([@B38]), and skin ([@B18]). Our previous work indicated that AlNP can cause neurotoxicity both *in vivo* and *in vitro* ([@B76], [@B75]). However, no studies have addressed whether AlNP induces developmental toxicity, and in particular, neurodevelopmental toxicity.

Previous research on metal oxidative NPs found developmental toxicity induced by nano-silver ([@B67]; [@B14]; [@B22]; [@B47]), nano-silica ([@B70]), graphene oxide ([@B11]; [@B46]), zinc oxide ([@B8]; [@B77]; [@B35]; [@B62]), iron oxide ([@B19]), copper oxide ([@B37]; [@B26]; [@B65]), magnesium oxide ([@B27]), titanium dioxide ([@B56]; [@B45]; [@B54]; [@B10]), and cerium oxide ([@B3]). Moreover, studies have shown that bulk-Al, once entering the brain, persists for a very long time with a half-life ranging from 20% of the lifespan to greater than the entire lifespan ([@B71], [@B72]; [@B50]; [@B23]). Due to the continuing accumulation in brain, bulk-Al compound can lead to both neurotoxicity ([@B42]) and developmental toxicity ([@B49]; [@B1]). In particular, bulk-Al can incorporate into the brain of the fetus following gestational exposure of female mice ([@B17]; [@B73]). Since AlNP belong to the group of metal oxidative NPs and have Al compound as its basic chemical component, we hypothesized that AlNP could induce neurodevelopmental toxicity.

Given the high susceptibility of the central nervous system (CNS) to external insults during the developmental period, we address specific concerns on neurodevelopmental toxicity effects of AlNP in the present study. Female mice were treated with AlNP at 13 or 50 nm particle sizes via nasal drip delivery prior to and throughout the entire pregnancy. Physical developmental and motor maturation levels of the pups were tracked as indicators of neurotoxicity, anxiety, and cognitive performance of adolescents and were used to confirm the neurotoxic effect; the underlying mechanism was explored as well. To our best knowledge, this study is the first investigation regarding neurodevelopmental toxicity of AlNP and warrants further studies to address potential neurodevelopmental toxicity associated with NPs.

Materials and Methods {#s1}
=====================

Characterization of AlNP
------------------------

Bulk-Al (10 μm particle size) and AlNP (13 and 50 nm particle sizes) were all purchased from Sigma-Aldrich Corporation (St. Louis, MO, United States). NP stock suspensions were freshly prepared in double distilled (dd) water. Ultrasonic vibration (100 W, 30 kHz) was performed for 30 min before use. AlNP were characterized using a transmission electron microscope (TEM) and the diameters were analyzed by Image-pro plus software. Zeta potential of AlNP was analyzed with a Nano Zetasizer (Malvern Instrument, Ltd., Malvern, United Kingdom).

For the TEM, a droplet of AlNP suspension was placed on a 200-mesh Cu-lacy carbon TEM grid (EM Sciences, Hatfield, PA, United States), and was allowed to dry overnight in a vacuum oven at room temperature. After evaporation, the AlNP were dispersed on the TEM grid. Observation and imaging were performed using a JEOL 2010f instrument (JEOL, Tokyo, Japan) with an operating voltage of 200 kV.

Zeta potential of NPs was measured by a Zetasizer (Malvern Instruments, Ltd.) at 25°C. NP stock was diluted 1:4 in double distilled water and measured in triplicates with 20 sub-runs. The samples were stored for 2 h to achieve equilibrium, and put into an ultrasound bath to disperse any aggregates before the zeta potential measurements.

Experimental Animals and Treatments
-----------------------------------

Thirty-six adult ICR mice (25--30 g, 12 males and 24 females) were purchased from Chinese Science Academy Animal Research Institute, and acclimatized for 1 week before the start of the experiment. The animal experiments were performed in accordance with the "Policies on the Use of Animals and Humans in Neuroscience Research" published by the *Society for Neuroscience* in 1995. The protocol was approved by the Animal Administration and Ethics Committee of Shanxi Medical University. All the mice were fed with homemade standard laboratory food (Shanxi Medical University, China) and water *ad libitum* at (23 ± 3)°C, relative humidity of (50 ± 10)%, a 12 h light/dark cycle, and ventilation of (10--20) times/h. Temperature and relative humidity were monitored daily. After acclimation, 24 female mice were randomly divided into four groups, six for each group, which were treated with 25--35 μL of saline control, bulk-Al, or AlNP (50 or 13 nm particle sizes) by nasal drip three times/day at the concentration of 50 mg/kg of body weight. The female mice were mated with healthy untreated male mice overnight after a 2-week treatment period. The male mice were removed after successful mating and the female mice were continually exposed to the treatments until birth of offspring. Pups were randomly chosen from each litter group for tests, two pups for detection of aluminum content, eight pups for body weight and neuromotor maturation tests, and two adolescents (one male and one female) for Openfield and Morris water maze (MWM) task. In total, 12 pups from each treatment group were used for aluminum content measurement, 48 pups for body weight and neuromotor maturation tests, and 12 adolescents (six males and six females) for Openfield and MWM task followed by oxidative stress and neurotransmitter levels' measurement (**Figure [1](#F1){ref-type="fig"}**).

![Flowchart of experimental design. Twenty-four female mice were randomly divided into four groups and were treated with saline control, bulk-Al, or AlNP (50 or 13 nm particle sizes) during pregnancy, respectively. Aluminum content and body weight were measured in newborns, neuromotor maturation tests were tracked in pups, and Openfield and Morris water maze task were performed in adolescents followed by oxidative stress and neurotransmitter levels measurement.](fphar-09-00253-g001){#F1}

Body Weight
-----------

Body weight (BW) used as an indicator of development was tracked in newborn pups every 3 days from postnatal day (PD) 1 through PD28.

Aluminum Content in the Hippocampus of Newborns
-----------------------------------------------

Newborns were anesthetized with 75% ice-cold ethanol for 2 min. Next, brains were carefully removed, and the hippocampus was dissected on an ice-cold glass tube. Then, the hippocampus was digested with a multi-wave 3000 sample preparation system (PerkinElmer, Inc., Shelton, WA, United States) according to the manufacturer's instruction. In the presence of 5% HNO~3~, aluminum content of samples was analyzed using graphite furnace atomic absorption spectrometry as previously described with minor modifications ([@B28]).

Physical Assessment During Development
--------------------------------------

Physical developmental landmarks are morphological indicators of development. Examples of such landmarks, including ear pinna open, eye opening, and teeth appearance, were observed in the developing offspring starting from PD1 through the entire developing period until PD28. The exact day in which the neonatal ear pinna completely detached from the head, both eyes opened, and the emergence of teeth through the gum line was recorded.

Assessment of Neuromotor Maturation During Developing Period
------------------------------------------------------------

To assess neuromotor maturation and general behavioral profiles in offspring of AlNP-treated female mice, a routine testing battery was performed on each pup.

### Righting Reflex

A pup was placed in a supine position on a rough horizontal board and righting reflex was determined to be present if the pup was able to flip itself to the normal dorso-ventral position within 2 min. The test was performed twice for each pup on both PD4 and PD7.

### Cliff Avoidance

A pup was placed on a platform (30 cm height) with its forepaws touching the edge and head facing outwards from the center of the platform. Cliff avoidance was considered positive if the pup moved its body away from the "cliff" within a 1 min.

### Endurance Test

It is also referred to as the forelimb grip strength test. Endurance was measured on PD12 and PD14. The forelimbs of pups were positioned on a wooden pole with a diameter of 0.5 cm. The amount of time that the pup was able to grasp the pole was recorded.

Behavioral Tests for Adolescents
--------------------------------

The Openfield and MWM tests were used to evaluate anxiety and cognitive performance in adolescent mice.

### Openfield Test

The Openfield test was conducted on PD28. General motion in a grid was measured in an Openfield apparatus, consisting of a square wooden arena with surrounding walls (80 cm × 80 cm × 30 cm). The floor of the arena was divided into 64 squares of equal size. The visual observations in the arena lasted 300 s for each mouse. The path of mouse was recorded by a video camera (Sony CCD-IRIS model) that was placed above the arena and was connected to a VHS videocassette recorder (Panasonic AG-5700 model). The video tracking program Etho-Vision (Noldus Information Technologies, Wageningen, Netherlands) was used to record the total distance traveled in 16 central grids and the total duration that the mouse stayed in the center grids. If the mouse reared (forelimbs upright against the wall) or groomed for longer than 3 s, these behaviors were also recorded.

### Morris Water Maze Task

Learning and memory performance of the adolescent mice were tested using MWM task. The water maze consists of a galvanized white circular water tank (90 cm diameter, 50 cm height) filled with clear tap water (22 ± 1°C) to a depth of 15 cm. A 6 cm × 6 cm invisible escape platform was placed 1 cm below the water level and 13 cm from the rim. The water was made opaque by adding white non-toxic paint. The MWM task was performed as previously described ([@B74]). Briefly, each mouse underwent daily sessions of four trials for four consecutive days. For each trial, the mouse was released into the water facing the wall at one of the four standard start locations selected at random (N, S, W, or E). When it succeeded in locating the platform, the mouse was allowed to remain on the platform for 15 s. If the mouse failed to find the platform within 60 s, it was assisted by the experimenter and allowed to remain on the platform for the same amount of time. The interval between trials was 20 min. A probe trial was performed 24 h after the last training session. For the probe trial, the platform was removed from the tank and the mouse was allowed to swim freely for 60 s. The experimenters conducted the trials while blind to the group assignments. All of the trials were videotaped using a camera located 2 m above the water surface. The time required to locate the hidden platform in the training trial (latency) and the time spent in as well as the number of entries into the target quadrant during the probe trial were recorded.

Oxidative Stress Levels in Cerebral Cortex of Adolescents
---------------------------------------------------------

Superoxide dismutase (SOD) and malondialdehyde (MDA) were measured to assess oxidative stress and damage. Six samples of cerebral cortex were dissected from adolescents 24 h after the last behavioral test. Tissue samples were homogenized in 100× volumes of ice-cold 0.1 mol/L phosphate buffer solution (containing 300 mmol/L sucrose and 0.1 mmol/L ethylenediamine tetra acetic acid and adjusted to pH 7.8) to yield a 1% (w/v) homogenate. This was then centrifuged at 4°C at 10,000 ×*g* for 10 min. Protein concentration was determined by the dye binding in a Bradford assay using bovine serum albumin as a standard. SOD and MDA contents were assayed using commercially available kits according to the manufacturer's protocol (Nanjing Jiancheng Bioengineering Institute, China).

Neurotransmitter Enzyme Activity
--------------------------------

Choline acetyltransferase (ChAT) and total cholinesterase (TChE) were assessed as potential mechanism underlying cognitive dysfunction in adolescent mice, since ChAT and TChE have been shown to be directly associated with acetylcholinergic content in rodents ([@B63]). Biochemical tests for cholinergic enzymes were conducted in adolescents 24 h after the last behavioral test. Half of the cerebral cortex from each mouse was dissected and homogenized with ice-cold 150 mM KCl. The homogenate (10% w/v) was centrifuged at 10,000 ×*g* for 15 min, and the supernatant was used for analysis. TChE activity was measured by the modified Ellman's colorimetric method ([@B21]; [@B32]), and ChAT activity was measured using the chemiluminescence assay described previously ([@B66]).

Statistical Analysis
--------------------

For quantitative data, the data are expressed as mean ± standard deviation ( ± s). One-way analysis of variance (ANOVA) is used to test the difference between means of the four subgroups of a variable (multiple testing) following by Dunnett's *post hoc* test to evaluate the statistical difference between the experimental groups and the controls, and Student--Newman--Keuls (SNK) test to assess the difference between experimental groups. For categorical data, the data are expressed as numbers of categorical counting, and the difference among groups and between any other two groups is analyzed by χ^2^ test. All data were analyzed with SPSS 12.0 (SPSS, Chicago, IL, United States). A *p*-value less than 0.05 is considered to be statistically significant.

Results
=======

Characteristics of Bulk-Al and AlNP
-----------------------------------

The primary characterization of particles was observed under TEM (**Figure [2](#F2){ref-type="fig"}**). Since NPs often form agglomerates in a solution, the size of the NPs and their agglomerates were estimated by Image-pro plus software. The TEM images in **Figure [2](#F2){ref-type="fig"}** display AlNP at 13 nm (**Figure [2A](#F2){ref-type="fig"}**), 50 nm (**Figure [2B](#F2){ref-type="fig"}**), and bulk-Al (**Figure [2C](#F2){ref-type="fig"}**) size in both agglomerated and non-agglomerated states. The particle size was distributed over a wide range due to differences in characteristics such as aggregation, mean diameters, and zeta potentials (**Table [1](#T1){ref-type="table"}**).

![Morphology of AlNP and bulk-Al under a transmission electron microscope (TEM). To observe the morphology of and measure their particle size, AlNP and bulk-Al particles were characterized under a TEM. **(A)** AlNP of 13 nm particle size (bar = 100 nm). **(B)** AlNP of 50 nm particle size (bar = 100 nm). **(C)** Bulk-Al of 10 μm particle size (bar = 10 μm).](fphar-09-00253-g002){#F2}

###### 

Particle-size and potential of AlNP and bulk-Al.

  Subjects          Characteristics    
  ----------------- ------------------ ------------
  13 nm AlNP        20.9 ± 9.5         49.4 ± 2.2
  50 nm AlNP        112.4 ± 24.5       44.3 ± 9.1
  Bulk-Al (10 μm)   8.592 ± 1.1 (μm)   

Newborn Pups Delivered by AlNP-Treated Female Mice Had Lower BW and Higher Al Content in the Hippocampus
--------------------------------------------------------------------------------------------------------

The consumption of food and water appeared normal for all treated female mice. However, the newborn pups delivered by AlNP-treated mice had significantly lower BW on PD1 compared with controls \[*F*~(3,188)~ = 30.14, *p* \< 0.0001; **Figure [3A](#F3){ref-type="fig"}**\]. Al contents in the hippocampus of PD1 pups delivered by AlNP-treated mice were significantly higher compared with those by controls \[*F*~(3,44)~= 106.1, *p* \< 0.0001\]. There was a significant decrease in the birth weight of pups delivered by female mice treated with both 50 and 13 nm AlNP compared with those treated with bulk-Al and normal saline controls (bulk-Al vs. control, *p* = 0.0109; 13 and 50 nm AlNP vs. bulk-Al and control, *p* \< 0.0001; 13 vs. 50 nm AlNP, *p* \< 0.0001; **Figure [3B](#F3){ref-type="fig"}**). Weight gain of pups in bulk-Al and AlNP groups significantly increased from PD4 to PD7 to PD14 and to PD28 \[*F*~(4,187)~= 116.9, *p* \< 0.0001\], but comparison of the actual body weight of pups at various weight days had no significant difference among groups \[*F*~(3,188)~= 0.5364, *p* = 0.6587; **Figure [3C](#F3){ref-type="fig"}**\].

![Body weight (BW) and Al contents in the newborn pups delivered by AlNP-treated female mice. To evaluate the accumulation of Al in the newborn brains, Al contents were measured using graphite furnace atomic absorption spectrometry (GFAAS). BW of newborns was used to assess the general impact of AlNP and bulk-Al particles on their next generations. The BW of PD1 newborns was significantly lower in AlNP-treated groups compared with the controls **(A)**. Al contents in the hippocampus of PD1 newborns significantly increased in bulk-Al vs. control, AlNP vs. bulk-Al and control, and 13 vs. 50 nm AlNP-treated mice **(B)**. The difference of BW in treated mice was not significant among groups though BW within each group increased by days **(C)**. a: *p* \< 0.05, compared with controls; b: *p* \< 0.05, compared with bulk-Al group; and c: *p* \< 0.05, compared with 50 nm AlNP group.](fphar-09-00253-g003){#F3}

Newborn Pups Delivered by AlNP-Treated Female Mice Had Lower Physical Values
----------------------------------------------------------------------------

Ear pinna structure, appearance of teeth, and eye opening of the newborn pups were recorded in **Table [2](#T2){ref-type="table"}**. The time needed for ear pinna opening among groups was significantly different \[*F*~(3,188)~= 17.69, *p* \< 0.0001\]; ear pinna opening was delayed significantly in bulk-Al and AlNP (13 and 50 nm) groups compared with controls (*p* \< 0.01). Further, AlNP (13 or 50 nm) groups were significantly delayed compared to bulk-Al group (*p* \< 0.01). Similarly, the time needed for teeth appearance among groups was significantly different \[*F*~(3,188)~= 85.64, *p* \< 0.0001\]; teeth appearance was delayed significantly in bulk-Al and AlNP (13 or 50 nm) groups compared with controls (*p* \< 0.01). Furthermore, pups delivered by female mice treated with 13 nm AlNP were significantly delayed compared with bulk-Al and 50 nm AlNP groups (*p* \< 0.01). Additionally, the time needed for eye opening was significantly different among groups \[*F*~(3,188)~= 7.42, *p* \< 0.0001\], which was significantly delayed in AlNP (13 or 50 nm) groups compared with control and bulk-Al groups (*p* \< 0.01), the 13 nm AlNP group displayed a greater delay in eye opening compared with 50 nm AlNP group (*p* \< 0.01).

###### 

Physical values in newborns delivered by AlNP-treated female mice (day).

  Groups       *N*   Ear pinna open    Teeth appearance    Eyes open
  ------------ ----- ----------------- ------------------- ------------------
  Control      48    4.38 ± 0.49       10.33 ± 0.47        15.04 ± 0.69
  Bulk-Al      48    4.83 ± 0.64^a^    11.11 ± 0.32^a^     15.17 ± 0.51
  50 nm AlNP   48    5.15 ± 0.54^ab^   11.15 ± 0.37^a^     15.31 ± 0.84^a^
  13 nm AlNP   48    5.11 ± 0.71^ab^   11.78 ± 0.61^abc^   15.69 ± 0.82^ab^

a

p \< 0.05, compared with controls;

b

p \< 0.05, compared with bulk-Al group; and

c

p \< 0.05, compared with 50 nm AlNP group.

Offspring Delivered by AlNP-Treated Female Mice Had Lower Level of Neuromotor Maturation
----------------------------------------------------------------------------------------

Neuromotor maturation of pups was evaluated and the results are shown in **Table [3](#T3){ref-type="table"}**. The number of righting reflex positive pups was significantly different among groups at PD4 (χ^2^= 2.856, *p* = 0.048), but no significance was found at PD7 (χ^2^= 1.644, *p* = 0.067). Compared with controls, the 13 nm AlNP group demonstrated lower righting reflexes (*p* \< 0.05), while no significance was found in bulk-Al and 50 nm AlNP groups (*p* \> 0.05). The number of cliff avoidance positive pups was significantly different among treated groups on PD4 (χ^2^= 4.397, *p* = 0.028) and PD7 (χ^2^= 6.12, *p* \< 0.001). Compared with controls, the bulk-Al (*p* \< 0.01, *p* \< 0.05), 50 nm (*p* \< 0.01, *p* \< 0.05), and 13 nm (*p* \< 0.05, *p* \< 0.05) AlNP groups had fewer cliff avoidance positive mice on PD4 and PD7.

###### 

Reflexing and sensation functions of the offspring delivered by AlNP-treated female mice.

  Groups       Righting reflex   Cliff avoidance                
  ------------ ----------------- ----------------- ---- ------- -------
  Control      48                21                37   37      39
  Bulk-Al      48                13                20   16^b^   21^a^
  50 nm AlNP   48                16                34   30^b^   37^a^
  13 nm AlNP   48                12^a^             29   26^a^   27^a^

Compared with controls,

a

p \< 0.05 and

b

p \< 0.01.

The effect of AlNP treatment on neuromotor development was evaluated on PD12 and PD14 by testing forelimb grip strength and endurance (**Table [4](#T4){ref-type="table"}**). Effects of particle sizes were observed with significant differences in forelimb grip strength among groups \[*F*~(3,188)~= 36.59, *p* \< 0.0001\]. On PD12, 50 and 13 nm AlNP groups had significantly lower forelimb grip strength compared with control and bulk-Al groups (*p* \< 0.01), but no significant difference was found between 50 and 13 nm AlNP groups (*p* \> 0.05). On PD14, bulk-Al, 50 nm, and 13 nm AlNP-treated mice had significantly lower forelimb grip strength compared with controls (*p* \< 0.01). Furthermore, the 13 nm AlNP group demonstrated significantly lower forelimb grip strength compared with bulk-Al and 50 nm AlNP groups (*p* \< 0.01), but no significant difference between bulk-Al and 50 nm AlNP groups was detected (*p* \> 0.05).

###### 

Forelimb grip strength in the offspring delivered by AlNP-treated female mice.

  Groups          *N*   Endurance duration (s)   
  --------------- ----- ------------------------ -------------------
  Control         48    14.80 ± 3.01             20.40 ± 2.95
  10 μm Bulk-Al   48    14.77 ± 3.58             16.86 ± 1.82^a^
  50 nm AlNP      48    11.28 ± 2.11^ab^         17.04 ± 2.25^a^
  13 nm AlNP      48    12.13 ± 3.20^ab^         13.67 ± 2.23^abc^

a

p \< 0.05, compared with controls;

b

p \< 0.05, compared with bulk-Al group; and

c

p \< 0.05, compared with 50 nm AlNP group.

Adolescents Delivered by AlNP-Treated Female Mice Displayed Greater Anxiety-Like Behavior
-----------------------------------------------------------------------------------------

Neurobehavioral performance was evaluated by anxiety, learning, and memory in 1-month-old adolescents by Openfield and MWM tests (**Figure [4](#F4){ref-type="fig"}**). For distance in the central grids of Openfield test (**Figure [4A](#F4){ref-type="fig"}**), significant difference was found among groups \[*F*~(3,44)~ = 4.554, *p* = 0.0061\]. The distance in central grids traveled by pups in the AlNP (50 and 13 nm) groups was significantly higher than that in control and bulk-Al treated groups (*p* = 0.047 and 0.0116), but no statistical significance was found between bulk-Al and controls (*p* = 0.8425). For duration in central grid (**Figure [4B](#F4){ref-type="fig"}**), no significant difference was found among groups \[*F*~(3,44)~ = 0.4194, *p* = 0.7396\]. For grooming times (**Figure [4C](#F4){ref-type="fig"}**), a significant difference was found among groups \[*F*~(3,44)~ = 35.83, *p* \< 0.0001\], though no significant difference was found between bulk-Al treated group and controls (*p* = 0.9891). However, there was a significant decrease in the 50 and 13 nm AlNP-treated groups (both *p* \< 0.0001) compared with bulk-Al and controls. In addition, no significant difference was found between 50 and 13 nm AlNP-treated groups (*p* = 0.8607). For rearing times (**Figure [4D](#F4){ref-type="fig"}**), a significant difference was found among groups \[*F*~(3,44)~= 27.70, *p* \< 0.0001\], though no significant difference was found between bulk-Al treated group and controls (*p* = 0.9329). However, there was a significant decrease in rearing times of 50 and 13 nm AlNP-treated groups (both *p* \< 0.0001) when compared with bulk-Al group and controls, but no significance between the AlNP-treated groups (50 and 13 nm; *p* = 0.1816).

![Anxiety scale of the adolescents delivered by AlNP-treated female mice. Openfield test was used to determine anxiety in the adolescents delivered by AlNP-treated female mice. The results are shown as distance in central grid **(A)**, duration in central grid **(B)**, grooming times **(C)**, and rearing times **(D)**. a: *p* \< 0.05, compared with controls and b: *p* \< 0.05, compared with bulk-Al group.](fphar-09-00253-g004){#F4}

Adolescents Delivered by AlNP-Treated Female Mice Had Worse Neurobehavioral Performance
---------------------------------------------------------------------------------------

Morris water maze task was used to determine learning and memory performance in adolescents delivered by AlNP-treated female mice (**Figure [5](#F5){ref-type="fig"}**). The adolescents demonstrated a significant decrease (**Figure [5A](#F5){ref-type="fig"}**) in learning performance within 5-day training \[*F*~(4,235)~= 42.93, *p* \< 0.0001\] with particle-size effects among groups \[*F*~(4,235)~= 4.452, *p* = 0.0044\]. No significant difference was found between bulk-Al treaded group and controls (*p* = 0.6223), but a significant decrease in learning was found in 50 (*p* = 0.0410) and 13 nm (*p* = 0.0053) AlNP-treated groups compared with controls. However, no significant difference was found between bulk-Al group and 50 (*p* = 0.4691) and 13 nm (*p* = 0.1473) AlNP-treated groups, nor between the 50 and 13 nm AlNP-treated groups (*p* = 0.9064).

![Learning and memory performance in the adolescents delivered by AlNP-treated female mice. Morris water maze was used to assess learning and memory performance in the offspring delivered by AlNP-treated female mice. Learning **(A)** and memory **(B,C)** performance of the offspring delivered by AlNP-treated female mice was displayed. a: *p* \< 0.01 compared with controls and b: *p* \< 0.01, compared with bulk-Al group.](fphar-09-00253-g005){#F5}

Memory profiles also differed in the amount of time spent in the target arm (**Figure [5B](#F5){ref-type="fig"}**) among groups \[*F*~(3,44)~= 14.92, *p* \< 0.0001\]. No significant difference was found compared bulk-Al (*p* = 0.0942) and 50 nm AlNP-treated groups (*p* = 0.4299), but adolescents in 13 nm AlNP-treated group spent less time in the target arm (*p* = 0.0006) compared with controls. Compared with bulk-Al, adolescents in 50 (*p* = 0.0.0014) and 13 nm (*p* \< 0.0001) AlNP-treated groups spent less time in target arm but no significance was found between 50 and 13 nm AlNP-treated groups (*p* = 0.0529). There was also a significant decrease in the number of entries into the target arm (**Figure [5C](#F5){ref-type="fig"}**) among groups \[*F*~(3,44)~ = 60.29, *p* \< 0.0001\]. Compared with controls, adolescents in bulk-Al (*p* \< 0.0001) and 50 and 13 nm AlNP-treated groups (both *p* \< 0.0001) all had less entries to the target arm, while those in 50 and 13 nm AlNP-treated groups had much less entries compared with that in bulk-Al group (**Figure [5](#F5){ref-type="fig"}**, both *p* \< 0.0001), though no significance was found between 50 and 13 nm AlNP-treated groups (*p* = 0.9997).

Oxidative Stress in Adolescents Delivered by AlNP-Treated Female Mice
---------------------------------------------------------------------

Superoxide dismutase activity and MDA products in the cerebral cortex were measured to evaluate oxidative stress in adolescents delivered by AlNP-treated female mice (**Figure [6](#F6){ref-type="fig"}**). SOD activity was significantly different among groups \[**Figure [6A](#F6){ref-type="fig"}**, *F*~(3,44)~ = 38.5, *p* \< 0.0001\]. Compared to controls, SOD activity in bulk-Al and AlNP (50 and 13 nm) treated groups was significantly lower (*p* \< 0.0001 for all). No significance was found between bulk-Al and 50 nm AlNP-treated groups (*p* = 0.4365), while SOD activity in 13 nm AlNP-treated mice was significantly lower compared with those in bulk-Al and 50 nm AlNP-treated groups (*p* = 0.0387 and 0.0008). For MDA products, though a significant difference in MDA products in the cerebral cortex among groups was found \[**Figure [6B](#F6){ref-type="fig"}**, *F*~(3,44)~= 3.121, *p* = 0.0417\], no significant difference (*p* \> 0.05) was found between any two groups (*p* \> 0.05).

![Oxidative stress in the cerebral cortex of the adolescents delivered by AlNP-treated female mice. To explore the mechanism involved in the neurobehavioral deficits, oxidative stress levels in the cerebral cortex were quantified. SOD activity **(A)** and MDA products **(B)** as measurements of oxidative stress were examined. There was a significant difference in both SOD activity and MDA products among groups. a: *p* \< 0.05, compared with controls; b: *p* \< 0.05, compared with bulk-Al group; and c: *p* \< 0.05, compared with 50 nm AlNP group.](fphar-09-00253-g006){#F6}

Neurotransmitter Levels in the Cerebral Cortex of Adolescents Delivered by AlNP-Treated Female Mice
---------------------------------------------------------------------------------------------------

Neurotransmitter enzyme levels of ChAT and TChE were measured in the cerebral cortex of adolescents delivered by AlNP-treated female mice (**Figure [7](#F7){ref-type="fig"}**). ChAT activity was significantly different among groups \[**Figure [7A](#F7){ref-type="fig"}**, *F*~(3,44)~ = 368.3, *p* \< 0.0001\]. Compared to controls, ChAT activity in bulk-Al and AlNP-treated groups (50 and 13 nm) was significantly decreased (*p* \< 0.0001 for all). Although ChAT activity in bulk-Al vs. 50 nm AlNP-treated mice did not differ (*p* = 0.9653), mice in 13 nm AlNP-treated group had significantly lower levels of ChAT compared to bulk-Al and 50 nm AlNP-treated mice (*p* \< 0.0001 both). For TchE activity, a significant difference among groups was found \[**Figure [7B](#F7){ref-type="fig"}**, *F*~(3,44)~ = 34.6, *p* \< 0.0001\]. Though no significance was found between bulk-Al treated group and controls (*p* = 0.5440), the TChE activity in AlNP (50 and 13 nm) treated groups was significantly higher compared with bulk-Al treated group and controls (*p* = 0.0001 and *p* \< 0.0001). There was no significance found between 50 and 13 nm AlNP groups on TChE activity (*p* = 0.1460).

![Neurotransmitter levels in cerebral cortex of adolescents delivered by AlNP-treated female mice. To explore the mechanism involved in the neurobehavioral deficits, neurotransmitter levels in the cerebral cortex were quantified. Choline acetyltransferase **(A)** and total cholinesterase activities **(B)** were examined. a: *p* \< 0.05, compared with controls; b: *p* \< 0.05, compared with bulk-Al group; and c: *p* \< 0.05, compared with 50 nm AlNP group.](fphar-09-00253-g007){#F7}

Discussion
==========

The developing nervous system is especially vulnerable to toxic chemical exposures ([@B53]; [@B7]), and major windows of developmental vulnerability occur *in utero* and during infancy and early childhood ([@B52]). During these sensitive life stages, exposure to chemicals, even at low concentrations, can cause permanent brain injury that can manifest as functional impairments or disease at any point in the human lifespan---from early infancy to old age. With the rapid development of nanotechnology, the likelihood of environmental exposure to NPs has significantly increased either actively or passively ([@B57]). Although BBB and blood--placental barrier can provide some protection against the entry of external products into the CNS during fetal development and early infancy, exposure to untested NPs should not be presumed safe. As new products with distinguished chemical and physical characteristics differ from their bulk counterparts, NPs in existing use and all new products must therefore be tested for developmental neurotoxicity ([@B29]).

The placenta is a multifunctional organ constituting the barrier between maternal and fetal tissues. Research has shown that NPs can cross the placental barrier ([@B34]; [@B40]), and there is increasing evidence that the extent of transfer is dependent on particle characteristics and functionalization ([@B69]; [@B64]). It is reported that exposure of pregnant mice to different NPs induces pregnancy complications or damage to the fetus (e.g., to silver NPs, titanium dioxide, silicon dioxide, and carbon nanotubes) ([@B59]; [@B30]; [@B48]; [@B68]; [@B12], [@B13]; [@B31]; [@B51]). Given the high susceptibility of the CNS to external insults during the developmental period, we address specific concerns on neurodevelopmental toxicity effects of AlNP in the present study.

Since developmental events are intertwined in the reproductive process, effects on developmental toxicity may be detected in developmental combined reproductive studies. Evaluation of the developmental effects in the present study is based on the National Toxicity Program Criteria from the U.S. Department of Health and Human Services for Levels of Evidence for Developmental Toxicity ([@B24]). A standard Reproductive/Developmental Toxicity Screening Assay ([@B43]) is used in female mice dosed with AlNP for 2 weeks prior to mating, during mating, and throughout gestation until the pups were born. Compared with developmental toxicological experiments that treatments are designed to start from the first day of mating, our experimental design of treatment starting from 2 weeks before mating considers the potential toxicity *in utero* to the female and toxicological consequences in the offspring.

First, the BW of newborn developing pups delivered by AlNP-treated female mice decreased significantly while Al contents in the hippocampus of PD1 newborns were increased (**Figure [3](#F3){ref-type="fig"}**). It was found that BW of the newborns on PD1 was significantly lower in pups delivered by AlNP-treated female mice. Moreover, PD1 newborns in AlNP-treated groups had significant higher contents of Al element in the hippocampus, indicating that AlNP can enter the hippocampus of the embryos and result in greater neuronal damage due to known Al neurotoxicity. Furthermore, neurodevelopmental deficits persisted into adolescents even though their lower BW was reconciled on the following PD7--PD28.

Second, AlNP administration via nasal drip in pregnant female mice affected the physical developmental landmarks in their offspring (**Table [2](#T2){ref-type="table"}**). Development of morphological indicators including ear pinna structure, appearance of teeth, and eye opening of the newborn pups delivered by AlNP-treated female mice was significantly delayed compared to the controls. In particular, the smaller sized AlNP (13 nm) caused a greater delay in developmental characteristics compared to 50 nm AlNP-treated group, suggesting possible interference in molecular pathways involved in physical growth and development.

Third, AlNP suppressed CNS maturation in the offspring. Normal neuromotor responses, such as righting reflex and cliff avoidance, were reduced significantly (**Table [3](#T3){ref-type="table"}**) and the endurance test demonstrated worse neuromuscular skeletal development in the offspring delivered by AlNP-treated female mice (**Table [4](#T4){ref-type="table"}**). These findings suggest AlNP-induced defects in maturation of the offspring's CNS when AlNP are prenatally exposed to the developing fetus *in utero*. It is possible that continuous exposure to AlNP during fetal development *in utero* has a cumulative toxic effect in the developing brains. Persisting neurodevelopmental deficits are indicative of potentially irreversible neural damage or improper neurodevelopment.

Finally, adolescent offspring in AlNP groups demonstrated greater anxiety-like behavior (**Figure [4](#F4){ref-type="fig"}**) and decreased learning and memory performance (**Figure [5](#F5){ref-type="fig"}**), indicating that prenatal exposure of AlNP in female mice during pregnancy can have long-lasting changes in neurocognitive function of the offspring which continues through adolescence. Evidence of elevated oxidative stress (**Figure [6](#F6){ref-type="fig"}**) and decreased neurotransmitter levels (**Figure [7](#F7){ref-type="fig"}**) in cerebral cortex of the adolescents suggests that prenatal AlNP exposure can induce brain dysfunction in adolescents by promoting oxidative stress accumulation while suppressing availability of neurotransmitters. In fact, studies have demonstrated repeatedly that AlNP can induce ROS and reduce neurotransmitter content in brain ([@B55]; [@B25]; [@B61]; [@B58]).

Therefore, it is suggested in the present study that AlNP exposure of female mice during pregnancy can jeopardize the proper development of the brain in offspring, which is one of the most susceptible target organs during early perinatal period. It also appears that AlNP-induced neurodevelopmental deficits can persist into adulthood, as shown by altered anxiety-like behavior and cognitive function. An important line of evidence in this study was that oxidative stress and neurotransmitter enzyme levels in offspring were altered by AlNP exposure of female mice during pregnancy, although further work is necessary to determine whether these findings precede neurobehavioral outcomes and lead to neurodevelopmental deficits or whether altered neurophysiology brought by perinatal exposure to AlNP leads to elevated oxidative stress and reduced neurotransmitter contents. Further studies to examine the relationship between AlNP and neurodevelopment are needed to investigate associated mechanisms and potential therapeutic strategies during the perinatal period, before permanent changes to the brain have occurred.
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